GlobeImmune Lands $7,500,000 New Financing Round

  • Feed Type
  • Date
    2/14/2014
  • Company Name
    GlobeImmune
  • Mailing Address
    1450 Infinite Drive Louisville, CO 80027
  • Company Description
    GlobeImmune, Inc., is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapy products called Tarmogens for the treatment of cancer and infectious diseases.
  • Website
    http://www.globeimmune.com
  • Transaction Type
    Debt
  • Transaction Amount
    $7,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy